Red Light Therapy for Headaches and Migraines: Evidence, Mechanisms and Best Devices

TL;DR

• Red and near-infrared light therapy has a genuine and growing clinical evidence base for headache and migraine management, with a 2024 systematic review in Current Pain and Headache Reports concluding that light therapies including LLLT are promising, safe, and non-pharmacological interventions for chronic migraine that decrease headache frequency and improve quality of life.
• A 2018 randomised controlled trial found low-level laser therapy reduced headache days in chronic migraine patients comparably to Botox injections, with no side effects.
• Red and near-infrared light works through neuroinflammation reduction, mitochondrial ATP activation in neurons, COX-2 inhibition reducing prostaglandin-driven pain sensitisation, and improved cerebrovascular circulation. Near-infrared at 810 to 850nm and 1064nm penetrates the skull to reach cortical and vascular tissue directly.
• Green light at 525nm works through a completely different mechanism, activating opioid pain-modulating pathways via retinal ganglion cells. It is the one wavelength documented not to exacerbate photophobia during active attacks and may reduce acute migraine pain through ocular exposure.
• The most important distinction for migraine sufferers is between preventative use between attacks (red and NIR applied to the scalp, neck, and shoulders) and acute use during an active attack (avoid intense red light if photophobic; green light via the eyes may help acutely). Never direct any device at the eyes during panel or cap sessions.

Headaches and migraines represent one of the most significant causes of disability globally. The World Health Organisation estimates over one billion people experience migraine, making it the second leading cause of disability worldwide. For chronic migraine sufferers cycling through preventative medications, acute treatments, and procedures like Botox, the search for effective drug-free complementary approaches is ongoing and pressing.

Red light therapy has attracted serious clinical attention for headache and migraine over the past decade, with research now spanning randomised controlled trials, systematic reviews, and head-to-head comparisons against established medical treatments. This article covers the different mechanisms through which light therapy addresses headache and migraine, what wavelengths work and why, and how to use it effectively as a preventative and complementary tool.

Understanding Headaches and Migraines: Different Conditions, Overlapping Mechanisms

Headaches and migraines are distinct conditions that share some mechanistic overlap, which is why similar photobiomodulation approaches show benefit for both.

Tension-Type Headaches

The most common headache type, tension headaches are characterised by bilateral pressure or tightening pain, often described as a band around the head. They are driven primarily by muscle tension in the neck, shoulders, and upper back, sensitised pain receptors in the pericranial muscles, and in chronic presentations, central sensitisation of pain pathways. The peripheral muscular and vascular components are the most directly relevant to photobiomodulation treatment.

Migraines

Migraines are a neurological disorder characterised by intense, typically unilateral throbbing pain lasting 4 to 72 hours, often accompanied by nausea, vomiting, and heightened sensitivity to light (photophobia), sound (phonophobia), and smell. The underlying mechanism involves cortical spreading depression, a wave of electrical activity across the brain that triggers the cascade of neuroinflammation, vascular changes, and sensitisation of the trigeminal pain pathway that produces the migraine attack. Many migraines are also preceded by muscle tension in the neck and shoulders that represents a common triggering pathway.

Migraines occur in phases: prodrome (warning signs), aura in some sufferers (visual or sensory disturbances), the headache phase, and postdrome (the migraine hangover of fatigue and cognitive fog). Each phase represents different mechanistic targets for photobiomodulation.

How Red and Near-Infrared Light Works for Headaches and Migraines

Neuroinflammation Reduction

Chronic migraine and frequent headache involve sustained neuroinflammation in the trigeminal pathway and meningeal tissue. Near-infrared wavelengths at 810 to 850nm and 1064nm penetrate the skull to reach cortical and subcortical tissue, where the same COX-2 inhibition and pro-inflammatory cytokine reduction documented in peripheral tissue applications operates in neural tissue. Reducing neuroinflammation between attacks lowers the baseline level of central sensitisation that makes the nervous system prone to triggering the next episode.

Mitochondrial ATP Activation in Neurons

Neurons are among the most metabolically demanding cells in the body, and migraine is associated with mitochondrial dysfunction and reduced energy availability in cortical tissue between attacks. The primary photobiomodulation mechanism, cytochrome c oxidase activation increasing ATP production, directly addresses this neuronal energy deficit. Improved mitochondrial function in cortical neurons supports more stable electrical activity and may reduce the likelihood of cortical spreading depression that initiates the migraine cascade.

COX-2 Inhibition and Prostaglandin Reduction

Prostaglandins, particularly PGE2, play a key role in the sensitisation of the trigeminal pain pathway during migraine. Photobiomodulation inhibits COX-2 through the same mechanism that NSAIDs target, reducing prostaglandin synthesis and the pain sensitisation it drives. This is one mechanism behind both the acute pain-reducing effects documented in some studies and the preventative reduction in headache frequency with consistent treatment.

Improved Cerebrovascular Circulation

Nitric oxide released through cytochrome c oxidase activation improves cerebrovascular regulation, supporting more stable blood flow to cortical tissue. Vascular dysregulation is a key component of migraine pathophysiology, and improved nitric oxide-mediated vascular tone may support more consistent cerebral blood flow between attacks.

Muscle Tension Relief

For tension-type headaches and the neck-and-shoulder tension that triggers many migraines, near-infrared light applied to the cervical spine, upper trapezius, and suboccipital muscles reduces the local inflammation, improves circulation, and supports muscle recovery that directly addresses one of the most common headache trigger pathways. The anti-inflammatory and circulatory effects in neck and shoulder tissue are the same documented across musculoskeletal applications of photobiomodulation.

Green Light: A Completely Different Mechanism

Green light at 525nm works through an entirely different pathway from red and NIR photobiomodulation and deserves separate explanation because its application and delivery method differ significantly.

The mechanism involves intrinsically photosensitive retinal ganglion cells (ipRGCs) in the retina. These cells connect directly to pain-modulating pathways in the brain including the periaqueductal grey, which regulates descending pain inhibition. Green light uniquely activates these pathways in a way that increases endogenous opioid activity and reduces pain sensitivity, while white, blue, red, and amber light activate different retinal pathways that can worsen photophobia.

A landmark study from the Burstein lab at Harvard found that green light was the only wavelength that did not exacerbate migraine photophobia and pain, while other wavelengths worsened symptoms. A subsequent clinical study found that 10 weeks of green light exposure reduced migraine days from 7.9 to 2.4 per month on average, a reduction of almost 70% in attack frequency.

The critical distinction is that green light for migraine requires ocular exposure, meaning light entering the eyes to reach the retinal ganglion cells. This is fundamentally different from photobiomodulation applied to the scalp or skin. During an active migraine with photophobia, low-intensity green light viewed through the eyes may reduce acute pain, while bright light of any colour including red may worsen symptoms.

What the Research Shows

2024 Systematic Review: Light Therapy for Chronic Migraine

A comprehensive systematic review published in Current Pain and Headache Reports (2024) reviewed the evidence for light therapies in chronic migraine management. The review concluded that light therapies, particularly green light and LLLT, are promising, safe, and non-pharmacological interventions for treating chronic migraine, with documented decreases in headache frequency and improvements in quality of life across reviewed studies.

2018 RCT: LLLT vs Botox for Chronic Migraine

The most striking individual study in the headache photobiomodulation literature is a 2018 randomised controlled trial published in Arquivos de Neuropsiquiatria (Loeb et al.) comparing low-level laser therapy to botulinum toxin A (Botox) in 36 patients with chronic migraine. Participants kept pain diaries for 30 days before treatment, 30 days during, and 30 days after. Both groups achieved significant reductions in headache days over the treatment and follow-up period, with no significant difference between LLLT and Botox in primary outcomes. The LLLT group achieved comparable results to an established, widely-used clinical treatment with no adverse effects, no injections, and no downtime.

Vascular Photobiomodulation RCT: Tension-Type Headaches

A randomised clinical trial examining vascular photobiomodulation in patients with tension-type headaches found significant reductions in pain levels and meaningful improvements in daily functioning across multiple domains including pain interference with walking, work, sleep, and enjoyment of life. The study documented that photobiomodulation produced clinically significant functional improvements alongside pain reduction, not just marginal statistical differences in pain scores.

Preventative vs Acute Use: The Critical Distinction

For migraine sufferers, the distinction between preventative and acute use is essential and often overlooked in general red light therapy content.

Preventative Protocol: Between Attacks

The strongest evidence base supports red and NIR photobiomodulation as a preventative approach used consistently between migraine attacks. Three to five sessions per week of 15 to 20 minutes targeting the scalp, neck, and shoulders reduces neuroinflammation, supports cortical mitochondrial function, and addresses the muscle tension trigger pathways cumulatively. The Loeb RCT and the systematic review evidence is primarily preventative in nature. Most people notice meaningful reduction in attack frequency after four to eight weeks of consistent preventative use.

During an Active Attack

During an active migraine, photophobia makes bright light of any wavelength potentially aggravating. For people with significant photophobia during attacks, red light panels and cap devices should be avoided or used at very low intensity. If using during an attack, apply near-infrared to the neck and shoulders at a reduced setting without any direct facial or scalp exposure in a dimly lit room.

Green light via the eyes is the most appropriate light therapy during an active migraine attack for photophobic sufferers, as it is the only wavelength documented not to exacerbate photophobia and may actively reduce acute pain through the retinal ganglion pathway.

Postdrome Recovery

The postdrome phase, the migraine hangover of fatigue, cognitive fog, and residual discomfort, is where photobiomodulation's cellular recovery and neuroinflammation resolution effects are most relevant acutely. A gentle session of 10 to 15 minutes after the headache phase has resolved may support faster resolution of postdrome symptoms through the same mitochondrial and anti-inflammatory mechanisms.

Treatment Locations and Positioning

• Scalp and transcranial: NIR at 810 to 850nm and 1064nm penetrates the skull to reach cortical tissue. A scalp cap delivers consistent transcranial NIR across the full scalp surface. This is the most directly relevant positioning for addressing the cortical neuroinflammation and mitochondrial components of migraine.
• Neck and suboccipital region: The suboccipital muscles and upper cervical spine are critical trigger sites for both tension headaches and migraines. Panel or mat positioned at the posterior neck and upper shoulders addresses this directly.
• Upper trapezius and shoulders: Muscle tension in the upper trapezius is one of the most common migraine trigger pathways. Near-infrared applied to this region in preventative sessions reduces the muscular component of headache triggering.
• Eyes (green only, low intensity): Green light for the retinal ganglion pathway requires ocular exposure at low intensity. Standard red and NIR devices should never be directed at the eyes.

StreamShop Devices for Headaches and Migraines

Red Light Therapy Cap With 940nm

StreamShop's red light therapy cap with 940nm delivers red and 940nm near-infrared light across the full scalp in a comfortable wearable format designed for transcranial and scalp applications. For headache and migraine management, the cap is the most anatomically relevant device in the range: it sits directly on the scalp and delivers NIR through the skull to cortical tissue, targeting the neuroinflammatory and mitochondrial mechanisms of migraine at their source. The 940nm wavelength supports both direct cortical photobiomodulation and improved cerebrovascular circulation through scalp microvascular perfusion. For preventative protocols, three sessions per week of 15 to 25 minutes during headache-free periods is the most evidence-aligned approach for reducing attack frequency.

SS100 Class IIa Medical Grade Panel

StreamShop's SS100 class IIa medical grade panel delivers 160 mW/cm² or above at 15cm across nine wavelengths including 660nm, 810nm, 830nm, 850nm, and 940nm through a 30-degree focusing lens. For neck, shoulder, and upper back sessions targeting the muscular tension trigger pathways of both tension headaches and migraines, the SS100 positioned at the posterior neck and upper trapezius delivers high-irradiance multi-wavelength NIR to the most common headache trigger region. Per-wavelength dimming allows the NIR channels to be prioritised for muscle and vascular applications, and the 10Hz pulse mode aligns with pain management protocols. As a class IIa ARTG-listed medical grade device, it meets the highest regulatory standard for at-home therapeutic devices in Australia.

Red Light Therapy Laser Mat With 1064nm

StreamShop's red light therapy laser mat with 1064nm combines LED and VCSEL laser technology across six wavelengths including 830nm, 850nm, 940nm, and 1064nm at 110 mW/cm² over a 1.8m x 80cm surface. For headache and migraine, lying on the mat with the posterior head and neck in direct contact with the 1064nm VCSEL laser technology delivers the deepest available transcranial and cervical penetration from a single device. The 1064nm wavelength reaches cortical and subcortical structures more effectively than standard 850nm LED, making the laser mat the most comprehensive transcranial and cervical spine treatment available in an at-home format. Whole-body sessions simultaneously address systemic inflammation and support sleep quality, both of which are closely associated with migraine frequency and severity. The 40Hz pulse mode is included for neurological protocol support.

Frequently Asked Questions

Does Red Light Therapy Help With Headaches and Migraines?

Yes. A 2024 systematic review concluded that light therapies including LLLT are promising, safe, and non-pharmacological interventions for chronic migraine with documented reductions in headache frequency. A 2018 RCT found LLLT produced comparable reductions in headache days to Botox injections with no adverse effects. The strongest evidence supports consistent preventative use between attacks rather than acute treatment during headache episodes.

Can Red Light Therapy Trigger a Migraine?

In people with significant photophobia, bright light of any wavelength including red can potentially trigger or worsen a migraine during an active attack. This is why red and NIR light therapy is most appropriate as a preventative protocol used between attacks rather than during active migraine episodes. During an active attack with photophobia, avoid bright red panels and reduce session intensity. Green light via the eyes is the most appropriate light therapy option during an active photophobic migraine.

What Wavelength Is Best for Migraines?

Near-infrared at 810 to 850nm and 940nm is most relevant for transcranial photobiomodulation targeting the neuroinflammatory and cortical mitochondrial mechanisms of migraine. For neck and shoulder muscle tension, the combination of red at 660nm and NIR at 850nm covers both surface and deep tissue. Green light at 525nm via ocular exposure targets a separate pain-modulating pathway and is most relevant during active attacks.

How Long Does It Take for Red Light Therapy to Help With Migraines?

Most people notice meaningful reduction in attack frequency after four to eight weeks of consistent preventative sessions, three to five times per week. The Loeb RCT documented significant reductions over a 30-day treatment period. Neuroinflammation reduction and cortical mitochondrial improvement are cumulative processes that build with consistent treatment rather than producing immediate single-session effects.

Where Should I Apply Red Light Therapy for Headaches?

The scalp (transcranial), posterior neck, and upper shoulders are the three primary treatment areas. The scalp cap addresses transcranial cortical delivery most directly. Panel or mat positioned at the posterior neck addresses the suboccipital and cervical trigger pathways. Upper shoulder and trapezius sessions address the muscular tension component. For comprehensive preventative management, covering all three areas in a single session or across alternating sessions produces the most complete coverage of headache mechanisms.

Is Red Light Therapy Safe to Use If I Have Chronic Migraines?

Yes, when used as a preventative protocol between attacks. Red and NIR light is non-ionising and has no known systemic effects or drug interactions. It is safe to use alongside all standard migraine medications including triptans, beta-blockers, topiramate, and Botox. If you are highly photophobic even between attacks, begin with very low intensity sessions and monitor your response. Discuss use with your neurologist if you are managing complex or refractory migraine.